Results 111 to 120 of about 15,580 (201)

Entecavir provides favorable virological control but minimal metabolic benefit in patients with Chronic Hepatitis B and MAFLD. [PDF]

Am J Transl Res
Wang B, Mo X, Wu X, Huang Y, Deng K, Liang Y, Lu Z, Wei H, Liang J, Huang Z.   +9 more
europepmc   +1 more source

A Rare Case of Myopathy Associated with Entecavir Initiation. [PDF]

J Pharm Technol
Overton C, Brock L, Betapudi B, Wells DA.   +3 more
europepmc   +1 more source

Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017 [PDF]

, 2019
Blach, Day, Degenhardt, Global Reporting System for Hepatitis, Heffernan, Hill, Hutin, Hutin, Hutin, Nayagam, Razavi, WHO, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Hepatitis Alliance   +22 more
core   +1 more source

Tenofovir vs. entecavir in chronic hepatitis B: A retrospective cohort study of hepatocellular carcinoma risk in a tertiary hospital in southern Brazil. [PDF]

Braz J Infect Dis
Stamm AN, Tovo CV, Noal A, Silva CU, Pizzi J, Fonseca PM, Kliemann DA.   +6 more
europepmc   +1 more source

Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254] [PDF]

, 2008
Barclay, Stephen, Benhamou, Yves, Cameron, Sheila, Carman, William, Hayes, Peter C, Mills, Peter R, Mutimer, David, Pol, Stanislas   +7 more
core   +1 more source

Exploratory analysis of lamivudine legacy and clonal selection of HBs truncation mutants in HBV-related hepatocellular carcinoma. [PDF]

Infect Agent Cancer
Chu YD, Ho PH, Hsu CW, Chiou CY, Lai MW, Yeh CT.   +5 more
europepmc   +1 more source

PG110 ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE: AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL [PDF]

, 2008
Connolly, M, Nielsen, SK, Currie, CJ, Poole, CD   +3 more
core   +1 more source

Real-World Effectiveness of Antiviral Prophylaxis for Preventing Hepatitis B Virus (HBV) Reactivation in Patients Undergoing Immunosuppressive Therapy. [PDF]

Viruses
Yılmaz Nakir İ, Çağlar B, Zerdali E, Karaduman RG, Pehlivanoğlu F.   +4 more
europepmc   +1 more source

Case Report: A rare pediatric case of hepatitis B virus infection with acute disseminated encephalomyelitis/Guillain-Barré syndrome spectrum diseases. [PDF]

Front Pediatr
Li Y, Hu D, Shen X, Mao X.
europepmc   +1 more source

Hepatitis B treatment response and factors associated with HBV treatment success: A population-based study in Rwanda. [PDF]

Hepatol Commun
Makuza JD, Law M, Ramji A, Jeong D, Puyat J, Aravindakshan A, Morrow RL, Adu PA, Nisingizwe MP, Cua G, Velásquez García HA, Berabose C, Tuyishime A, Janjua NZ.   +13 more
europepmc   +1 more source